We are live on
!
Find out more
RMCM
Reynders McVeigh Capital Management Portfolio holdings
AUM
$1.98B
1-Year Est. Return
23.37%
This Fund
S&P 500
This Quarter
Est. Return
+1.12%
1 Year Est. Return
+23.37%
3 Year Est. Return
+85.22%
5 Year Est. Return
+113.19%
10 Year Est. Return
+523.93%
AUM
$704M
AUM Growth
+$17.6M
(+2.6%)
Cap. Flow
+$17.6M
Cap. Flow
% of AUM
2.5%
Top 10 Holdings %
Top 10 Hldgs %
34.59%
Holding
228
New
17
Increased
78
Reduced
95
Closed
3
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
J.M. Smucker
SJM
|
+$2.94M |
| 2 |
PayPal
PYPL
|
+$2.45M |
| 3 |
NVO
Novo Nordisk
NVO
|
+$2.38M |
| 4 |
Analog Devices
ADI
|
+$1.8M |
| 5 |
Adient
ADNT
|
+$1.65M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Teva Pharmaceuticals
TEVA
|
+$1.63M |
| 2 |
IPG Photonics
IPGP
|
+$1.49M |
| 3 |
Perrigo
PRGO
|
+$1.24M |
| 4 |
Kroger
KR
|
+$1.05M |
| 5 |
Gilead Sciences
GILD
|
+$990K |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 25.52% |
| 2 | Technology | 19.56% |
| 3 | Industrials | 16.26% |
| 4 | Consumer Staples | 11.7% |
| 5 | Financials | 8.33% |
Similar funds
SC
CAM
TCM
RCM
LGM
MYAM
NIM
C
Reynders McVeigh Capital Management's Q4 2016 Portfolio in Review
As of Q4 2016, Reynders McVeigh Capital Management held 228 positions worth $704M, up 2.6% from $686M the previous quarter. Its ten largest holdings account for 35% of the portfolio.
Reynders McVeigh Capital Management's Q4 2016 filing shows 17 new, 78 increased, 95 reduced and 3 closed positions. Its largest new stake was Adient: 31,202 shares worth $1.83M. The largest sale was Teva Pharmaceuticals, an estimated $1.63M.
By sector, the portfolio is most concentrated in Healthcare at 26% of assets, down from 28% a quarter earlier, followed by Technology and Industrials.
- Reynders McVeigh Capital Management's largest Q4 2016 buy was Adient: 31,202 shares worth $1.83M.
- Reynders McVeigh Capital Management added most to J.M. Smucker in Q4 2016, an estimated $2.94M increase.
- Reynders McVeigh Capital Management's biggest Q4 2016 reduction was Teva Pharmaceuticals, cutting an estimated $1.63M.
- Reynders McVeigh Capital Management fully exited Blackrock in Q4 2016, selling an estimated $275K.
- Reynders McVeigh Capital Management's ten largest holdings make up 35% of its $704M portfolio in Q4 2016.
- Reynders McVeigh Capital Management opened 17 new positions and closed 3 in Q4 2016.
- Reynders McVeigh Capital Management's portfolio value rose 2.6% quarter-over-quarter to $704M.
Based on Reynders McVeigh Capital Management's 13F filing for Q4 2016, filed 14 Feb 2017.